Showing results (71-80 of 124) with videos related to
Sort By:
Pageof 13
Fortschritte Der Medizin|February 9, 1984
[Hepatitis B and the delta agent]W Jilg, M Roggendorf, G Zoulek, et al.Journal of Medical Virology|August 10, 1999
Prevalence of precore mutants in anti-HBe-positive hepatitis B virus carriers in GermanyA Knöll, A Rohrhofer, B Kochanowski, et al.Journal of Virology|October 10, 1998
Immediate-early transactivator Rta of Epstein-Barr virus (EBV) shows multiple epitopes recognized by EBV-specific cytotoxic T lymphocytesS Pepperl, G Benninger-Döring, S Modrow, et al.Virology|August 1, 1994
The Epstein-Barr virus-encoded glycoprotein gp 110 (BALF 4) can serve as a target for antibody-dependent cell-mediated cytotoxicity (ADCC)W Jilg, C Bogedain, H Mairhofer, et al.Journal of Medical Virology|May 21, 1999
A novel deletion mutant of hepatitis B virus surface antigenK M Weinberger, G Zoulek, T Bauer, et al.Vaccine|July 14, 1999
Diphtheria booster vaccination: one or two injections?U Nicolay, O E Girgsdies, A Banzhoff, et al.Hoppe-Seyler'S Zeitschrift Fur Physiologische Chemie|August 1, 1975
[Free-flow electrophoresis. I. Theoretical and experimental investigations of the influence of mechanical and electrokinetic variables on the efficiency of the method]K Hannig, H Wirth, B H Meyer, et al.Hoppe-Seyler'S Zeitschrift Fur Physiologische Chemie|July 1, 1977
Free-flow electrophoresis. III. An analytical version for a rapid, quantitative determination of electrophoretic parametersK Hannig, H Wirth, R K Schindler, et al.Vaccine|March 1, 1997
Long-term persistence of anti-HAV antibodies following active immunization with hepatitis A vaccineH Maiwald, W Jilg, H L Bock, et al.Journal of Virology|February 1, 1994
Different activation of Epstein-Barr virus immediate-early and early genes in Burkitt lymphoma cells and lymphoblastoid cell linesC Bogedain, P Alliger, F Schwarzmann, et al.Pageof 13